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This research has revealed that 15 kinds of Indonesian plants show various antiproliferative 
activities by using preliminary screening against four cancer cell lines, namely: A549, KB, 
MDA-MB-231, MCF7. An anti-inflammatory assay that inhibited production of NO and MTT 
assay on J774.1 cells and an antiangiogenesis assay on HUVEC were conducted. The aim was to 
study the potential benefits and to isolate bioactive compounds of Indonesian medicinal and 
non-medicinal plants. Methods: The plants were extracted using methanol and water for the 
preliminary assay. The preliminary assay was performed in this research for the screening of 
these plants. Antiproliferative activity was evaluated with an RSB assay, anti-inflammatory 
activity was examined with inhibition of NO production on LPS-induced J774.1 cells, 
anti-angiogenesis was performed on the inhibition of VEGF on HUVEC, and anti-HIV was 
investigated by MTT assay. Based on the data of the assays, specific plants were chosen for 
extraction, isolation and purification to create isolated compounds. The isolated compound 
identified the structure and evaluated the activity by using an anti-proliferative activity on 
several cancer cell lines.  Anti-inflammatory activity was examined by inhibition of NO 
production on LPS-induced J774.1 cells. Antiangiogenesis assay was performed on inhibition of 
VEGF on HUVEC , and anti-HIV assay was conducted on Cells MT4 and virus NL4-3. 
   It is recommended to further investigate the following six plants which are KNG, GHR, VCS, 
HJG, PDS, and KPS because they have shown significant activity during the preliminary assay. 
VCS was chosen for further investigation because it was the only plant that has yet to be 
explored. And also, one of the fractions after separation exhibited significant results against 
human cancer cell lines where the chloroform-soluble part of VCS was performed on silica gel 
flash column chromatography, recycle HPLC, and preparative TLC to derive 2 compounds. Both 
of the compounds were identified using Mass spectrum analysis, 1H-NMR, 13C-NMR, 2D NMR, 
ECD experiments and were compared with previous research. Compound 1 was identified as   
(3aR,6R,7S,7aR)-7-{(S)-2-hydroxy-2-[(R&S)-2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl]ethyl}-3,3a,6,
7-tetramethyl-3a,4,5,6,7,7a-hexahydro-1H-indene-2-carbaldehyde (IUPAC), namely 
16-hydroxy-pentandralactone. Compound 2 can be identified as acuminolide. Both of the 
compounds were examined through the antiproliferative assay against five human cancer cell 
lines such as A549, MDA-MB-231, KB, KB-Vin, MCF-7. Compound 1 and compound 2 showed 
bioactivity against five cancer cell lines, with IC50 5.4 – 11.4 µM (Table 8). Antiangiogenesis 
assay was also performed on both of the extracts, and compound 1 inhibited VEGF in a 
dose-dependent manner, but displayed no cytotoxicity against HUVEC. Compound 2 had 
cytotoxicity against HUVEC with cell viability 47% at concentration 3.0 µM. 
 
Conclusion: Six plants can be used as candidate plants for further examination because they 
show significant activity, which are flowers buds of Cananga odorata, stems of Aquilaria sp., 
seeds of Azadirachta indica, aerials of Pseudelephantopus spicatus, leaves of Chromolaena 
odorata, leaves of Cordyline and leaves of Vitex cofassus sp. Compound 1 was identified as 
(3aR,6R,7S,7aR)-7-{(S)-2-hydroxy-2-[(R&S)-2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl]ethyl}-3,3
a,6,7-tetramethyl-3a,4,5,6,7,7a-hexahydro-1H-indene-2-carbaldehyde (IUPAC), namely 
16-hydroxy-pentandralactone could be explored as an agent for anti-cancer because it exhibited 
bioactivity against five cancer cell lines lung carcinoma (A549), triple-negative breast cancer 
(MDA-MB-231), estrogen receptor-positive breast cancer (MCF-7), epidermoid carcinoma (KB), 
vincristine-resistant KB subline (KB-VIN) with IC50 6.4 -11.9 µM. Compound (1) also showed 
evidence of ability in assisting in problem-solving in multi-resistant drugs because it showed 
activity on cancer cells that are resistant to chemotherapy such as KB-VIN. This is supported by 
antiangiogenesis data which inhibited VEGF in a dose-dependent manner, but no cytotoxicity 
appeared on the HUVEC.Compound 2 exhibited significant activity against all the tested 
tumour cell line, and the IC50 5.4 – 8.9 µM and also had cytotoxicity against HUVEC with cell 

























とした。15 種類の植物材料の各 MeOH 及び熱水抽出エキスに対し三種類の生物活性試験
〔①ヒト由来がん細胞（A549、MDA-MB-231、MCF-7、KB）に対する増殖抑制作用、②NO
産生阻害（J774.1）による抗炎症作用、③血管内皮細胞増殖因子誘発ヒト臍帯静脈内皮細胞
に対する血管新生抑制作用〕を実施した。その結果、クマツヅラ科 Vitex cofassus 葉の
MeOH 抽出エキスを選択した。NO 産生阻害試験を指標に分離分画を繰り返した結果、新
規 化 合 物  (3aR,6R,7S,7aR)-7-{(S)-2-hydroxy-2-[(R&S)-2-hydroxy-5-oxo-2,5-dihydrofuran-3-yl] 
ethyl}-3,3a,6,7-tetramethyl-3a,4,5,6,7,7a-hexahydro-1H-indene-2-carbaldehyde 及び既知化合物 
acuminolide を得た。この新規化合物は生物活性試験①に対し、やや強い活性（IC50; 6.4-11.4 
µM）を、acuminolide は③に対し 53% の細胞毒性（3 µm）示すことを明らかにした。 
	 以上、本研究ではインドネシア産資源植物 15 種の抽出液について 3 種の生理活性を調査
した。さらに Vitex cofassus より新規を含む２化合物を単離し、得られた新規化合物ががん
細胞増殖抑制効果を示すことを明らかにした。この成果は学術的な重要性が期待できること
から審査委員会は本論文が博士（学術）に値すると判断した。 
